If you made any changes in Pure these will be visible here soon.

Research Output 1988 2020

Filter
Article
2009

High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: Results of a global phase 3b expanded access program

Mikhael, J. R., Belch, A. R., Prince, H. M., Lucio, M. N., Maiolino, A., Corso, A., Petrucci, M. T., Musto, P., Komarnicki, M. & Stewart, A. K., Jan 2009, In : British Journal of Haematology. 144, 2, p. 169-175 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Peripheral Nervous System Diseases
Neutropenia
Thrombocytopenia

Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects

Corso, A., Zappasodi, P., Barbarano, L., Petrucci, M. T., Palumbo, A., Caravita, T., Mangiacavalli, S., Cafro, A. M., Varettoni, M., Gay, F., Morra, E. & Lazzarino, M., Sep 2009, In : Leukemia Research. 33, 9

Research output: Contribution to journalArticle

Thalidomide
Multiple Myeloma
Steroids
Constipation
Survival
2008

DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients

Zappasodi, P., Nosari, A. M., Astori, C., Ciapanna, D., Bonfichi, M., Varettoni, M., Mangiacavalli, S., Morra, E., Lazzarino, M. & Corso, A., May 2008, In : Transfusion. 48, 5, p. 857-860 4 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Multiple Myeloma
Leukapheresis
Drug Therapy
Body Weight

Efficacy of Bortezomib followed by local irradiation in two patients with extramedullary plasmacytomas

Varettoni, M., Mangiacavalli, S., Zappasodi, P., Pica, G. M., Lazzarino, M. & Corso, A., May 2008, In : Leukemia Research. 32, 5, p. 841-843 3 p.

Research output: Contribution to journalArticle

Efficacy of Bortezomib followed by local irradiation in two patients with extramedullary plasmacytomas.

Varettoni, M., Mangiacavalli, S., Zappasodi, P., Pica, G. M., Lazzarino, M. & Corso, A., May 2008, In : Leukemia Research. 32, 5, p. 839-841 3 p.

Research output: Contribution to journalArticle

Immune-mediated neuropathies in myeloma patients treated with bortezomib

Ravaglia, S., Corso, A., Piccolo, G., Lozza, A., Alfonsi, E., Mangiacavalli, S., Varettoni, M., Zappasodi, P., Moglia, A., Lazzarino, M. & Costa, A., Nov 2008, In : Clinical Neurophysiology. 119, 11, p. 2507-2512 6 p.

Research output: Contribution to journalArticle

Poisons
Peripheral Nervous System Diseases
Therapeutic Uses
Proteasome Endopeptidase Complex
Therapeutics

Infiltration of the spinal cord in a patient with multiple myeloma

Varettoni, M., Corso, A., Zappasodi, P., Calliada, F., Castagnola, C., Mangiacavalli, S. & Lazzarino, M., 2008, In : Journal of Clinical Oncology. 26, 25, p. 4207-4209 3 p.

Research output: Contribution to journalArticle

Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapy

Corso, A., Mangiacavalli, S., Barbarano, L., Montalbetti, L., Mazzone, A., Fava, S., Varettoni, M., Zappasodi, P., Morra, E. & Lazzarino, M., Jul 2008, In : Leukemia Research. 32, 7, p. 1085-1090 6 p.

Research output: Contribution to journalArticle

Thalidomide
Multiple Myeloma
Dexamethasone
Transplants
Melphalan

The place of thalidomide in the treatment of multiple myeloma

Corso, A. & Mangiacavalli, S., Feb 2008, In : Oncology Reviews. 1, 4, p. 205-214 10 p.

Research output: Contribution to journalArticle

Thalidomide
Multiple Myeloma
Pharmaceutical Preparations
Drug Therapy
Biological Factors
2007
zoledronic acid
Osteonecrosis
Jaw
pamidronate
Multiple Myeloma

Late onset of bortezomib-associated cutaneous reaction following herpes zoster [4]

Varettoni, M., Vassallo, C., Borroni, G., Mangiacavalli, S., Zappasodi, P., Rosso, R., Lazzarino, M. & Corso, A., Apr 2007, In : Annals of Hematology. 86, 4, p. 301-302 2 p.

Research output: Contribution to journalArticle

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

Dimopoulos, M., Spencer, A., Attal, M., Prince, H. M., Harousseau, J. L., Dmoszynska, A., San Miguel, J., Hellmann, A., Facon, T., Foà, R., Corso, A., Masliak, Z., Olesnyckyj, M., Yu, Z., Patin, J., Zeldis, J. B. & Knight, R. D., Nov 22 2007, In : New England Journal of Medicine. 357, 21, p. 2123-2132 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Placebos
Thalidomide
Poisons

Limited feasibility of double transplant in multiple myeloma: Results of a multicenter study on 153 patients aged

Corso, A., Mangiacavalli, S., Barbarano, L., Alessandrino, E. P., Cairoli, R., Morra, E. & Laziarino, M., Jun 1 2007, In : Cancer. 109, 11, p. 2273-2278 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Multicenter Studies
Transplants
Lost to Follow-Up
Autografts

Severe intestinal vasculitis in a patient under treatment with bortezomib

Mangiacavalli, S., Zappasodi, P., Castagnola, C., Astori, C., Varettoni, M., Lazzarino, M. & Corso, A., 2007, In : Annals of Hematology. 86, 12, p. 923-924 2 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Stem Cells
Transplantation
Pharmaceutical Preparations
Therapeutics
2006

An update of the APEX study

Corso, A., 2006, In : Haematologica Reports. 2, 5, p. 2-4 3 p.

Research output: Contribution to journalArticle

Bortezomib: Introduction

Corso, A., 2006, In : Haematologica Reports. 2, 5, p. 1 1 p.

Research output: Contribution to journalArticle

Changes in multiple myeloma epidemiology in the last thirty years: A single centre experience

Zappasodi, P., Corso, A., Klersy, C., Pica, G., Mangiacavalli, S., Varettoni, M., Rusconi, C., Pascutto, C. & Lazzarino, M., Feb 2006, In : European Journal of Cancer. 42, 3, p. 396-402 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Epidemiology
Therapeutics
Monoclonal Gammopathy of Undetermined Significance
Recurrence

Mucocutaneous paraneoplastic syndromes in hematologic malignancies

Zappasodi, P., Del Forno, C., Corso, A. & Lazzarino, M., Jan 2006, In : International Journal of Dermatology. 45, 1, p. 14-22 9 p.

Research output: Contribution to journalArticle

Thrombomodulin levels are not modified during thalidomide treatment

Zappasodi, P., Mangiacavalli, S., Terulla, V., Airò, F., Klersy, C., Varettoni, M. & Corso, A., Nov 2006, In : European Journal of Haematology. 77, 5, p. 453-454 2 p.

Research output: Contribution to journalArticle

2005

Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection

Corso, A., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Klersy, C., Rusconi, C., Colucci, E., Lorenzi, A., Troletti, D., Consensi, E. & Lazzarino, M., Feb 2005, In : Leukemia Research. 29, 2, p. 159-163 5 p.

Research output: Contribution to journalArticle

Bone Marrow Cells
Stem Cells
Cell Count
Bone Marrow
Multiple Myeloma

Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma

Corso, A., Mangiacavalli, S., Nosari, A., Castagnola, C., Zappasodi, P., Cafro, A. M., Astori, C., Bonfichi, M., Varettoni, M., Rusconi, C., Troletti, D., Pascutto, C., Morra, E. & Lazzarino, M., Dec 2005, In : Bone Marrow Transplantation. 36, 11, p. 951-954 4 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Etoposide
Multiple Myeloma
Cyclophosphamide
Dexamethasone

Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: A possible mechanism for its antitumor effect

Corso, A., Ferretti, E., Lunghi, M., Zappasodi, P., Mangiacavalli, S., De Amici, M., Rusconi, C., Varettoni, M. & Lazzarino, M., Jul 1 2005, In : Cancer. 104, 1, p. 118-125 8 p.

Research output: Contribution to journalArticle

zoledronic acid
Multiple Myeloma
Mesenchymal Stromal Cells
Down-Regulation
Apoptosis

Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment

Corso, A., Ferretti, E. & Lazzarino, M., Jun 2005, In : Hematology. 10, 3, p. 215-224 10 p.

Research output: Contribution to journalArticle

zoledronic acid
Stromal Cells
Multiple Myeloma
Bone Marrow
Plasma Cells
2004

Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone

Corso, A., Lorenzi, A., Terulla, V., Airò, F., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Rusconi, C. & Lazzarino, M., Sep 2004, In : Annals of Hematology. 83, 9, p. 588-591 4 p.

Research output: Contribution to journalArticle

Thrombomodulin
Thalidomide
Dexamethasone
Venous Thrombosis
Combination Drug Therapy

Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls [8]

Corso, A., Dovio, A., Rusconi, C., Sartori, M. L., Klersy, C., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Ventura, M., Angeli, A. & Lazzarino, M., Sep 2004, In : Leukemia. 18, 9, p. 1555-1557 3 p.

Research output: Contribution to journalArticle

The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma

Corso, A., Barbarano, L., Zappasodi, P., Cairoli, R., Alessandrino, E. P., Mangiacavalli, S., Ferrari, D., Fava, S., Fiumanò, M., Frigerio, G., Isa, L., Luraschi, A., Klersy, C., De Paoli, A., Vergani, C., Banfi, L., Perego, D., Ucci, G., Pinotti, G., Savarè, M. & 4 others, Uziel, L., Vismara, A., Morra, E. & Lazzarino, M., Sep 2004, In : Haematologica. 89, 9, p. 1124-1127 4 p.

Research output: Contribution to journalArticle

Etoposide
Multiple Myeloma
Cyclophosphamide
Dexamethasone
Cisplatin
2003

Early changes in bone marrow morphology induced by thalidomide in patients with refractory myeloma

Corso, A., Lorenzi, A., Zappasodi, P., Invernizzi, R., Vanelli, L. & Lazzarino, M., Aug 1 2003, In : Haematologica. 88, 8, p. 958-960 3 p.

Research output: Contribution to journalArticle

Thalidomide
Bone Marrow
Erythroblasts
Megakaryocytes
Multiple Myeloma

Urinary proteins in multiple myeloma: Correlation with clinical parameters and diagnostic implications

Corso, A., Zappasodi, P., Pascutto, C., Bosoni, T., Mangiacavalli, S., Lorenzi, A., Rusconi, C. & Lazzarino, M., Aug 1 2003, In : Annals of Hematology. 82, 8, p. 487-491 5 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Kidney
Creatinine
Immunoglobulin G
Proteins
2002

A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma

Corso, A., Arcaini, L., Caberlon, S., Zappasodi, P., Mangiacavalli, S., Lorenzi, A., Rusconi, C., Troletti, D., Maiocchi, M. A., Pascutto, C., Morra, E. & Lazzarino, M., Oct 2002, In : Haematologica. 87, 10, p. 1041-1045 5 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Poisons
Etoposide
Multiple Myeloma
Cyclophosphamide

Advantages of using thalidomide for the management of patients with refractory myeloma

Corso, A., Lorenzi, A., Orlandi, E., Astori, C., Mangiacavalli, S. & Lazzarino, M., 2002, In : Haematologica. 87, 3, p. 327-328 2 p.

Research output: Contribution to journalArticle

Thalidomide
Outpatients
Clone Cells
Drug Therapy

Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis

Passamonti, F., Malabarba, L., Orlandi, E., Pascutto, C., Brusamolino, E., Astori, C., Baratè, C., Canevari, A., Corso, A., Bernasconi, P., Cazzola, M. & Lazzarino, M., 2002, In : British Journal of Haematology. 116, 4, p. 855-861 7 p.

Research output: Contribution to journalArticle

Pipobroman
Essential Thrombocythemia
Thrombosis
Therapeutics
Platelet Count

Successful therapy with high-dose steroids and cyclosporine for the treatment of carmustine-mediated lung injury

Zappasodi, P., Vitulo, P., Volpini, E., Castagnola, C., Nascimbene, C. & Corso, A., 2002, In : Annals of Hematology. 81, 6, p. 347-349 3 p.

Research output: Contribution to journalArticle

Carmustine
Lung Injury
Cyclosporine
Pneumonia
Steroids

The natural history of a solitary plasmacytoma

Corso, A., 2002, In : British Journal of Haematology. 118, 2, p. 350 1 p.

Research output: Contribution to journalArticle

Urinary proteins and renal dysfunction in patients with multiple myeloma

Corso, A., Zappasodi, P. & Lazzarino, M., 2002, In : Biomedicine and Pharmacotherapy. 56, 3, p. 139-143 5 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Kidney
Spontaneous Fractures
Proteins
Renal Insufficiency
2001

Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients

Corso, A., Arcaini, L., Mangiacavalli, S., Astori, C., Orlandi, E., Lorenzi, A., Passamonti, F., Klersy, C., Pascutto, C., Canevari-Sciorati, A. & Lazzarino, M., 2001, In : Haematologica. 86, 4, p. 394-398 5 p.

Research output: Contribution to journalArticle

Bone Diseases
Multiple Myeloma
Biomarkers
Monoclonal Gammopathy of Undetermined Significance
Osteocalcin

Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: A single center experience

Castagnola, C., Alessandrino, E. P., Lunghi, M., Bernasconi, P., Della Porta, M., Mangiacavalli, S., Colombo, A., Corso, A., Pagnucco, G., Lazzarino, M. & Bernasconi, C., 2001, In : Annals of Hematology. 80, 5, p. 267-271 5 p.

Research output: Contribution to journalArticle

Cell Transplantation
Acute Myeloid Leukemia
Blood Cells
Stem Cells
Consolidation Chemotherapy

DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma

Lazzarino, M., Corso, A., Barbarano, L., Alessandrino, E. P., Cairoli, R., Pinotti, G., Ucci, G., Uziel, L., Rodeghiero, F., Fava, S., Ferrari, D., Fiumanò, M., Frigerio, G., Isa, L., Luraschi, A., Montanara, S., Morandi, S., Perego, D., Santagostino, A., Savarè, M. & 2 others, Vismara, A. & Morra, E., 2001, In : Bone Marrow Transplantation. 28, 9, p. 835-839 5 p.

Research output: Contribution to journalArticle

Etoposide
Multiple Myeloma
Cyclophosphamide
Dexamethasone
Cisplatin

Thalidomide in refractory myeloma patients: Early changes in bone marrow cellularity

Zappasodi, P., Lorenzi, A. & Corso, A., 2001, In : Haematologica. 86, 4, p. 448 1 p.

Research output: Contribution to journalArticle

2000

Blood stem cell collections in multiple myeloma: Definition of a scoring system

Corso, A., Caberlon, S., Pagnucco, G., Klersy, C., Zappasodi, P., Alessandrino, E. P., Vanelli, L., Mangiacavalli, S., Lazzarino, M. & Bernasconi, C., 2000, In : Bone Marrow Transplantation. 26, 3, p. 283-286 4 p.

Research output: Contribution to journalArticle

Melphalan
Multiple Myeloma
Platelet Count
Blood Cells
Granulocyte-Macrophage Progenitor Cells

Outcome of patients with refractory/relapsed aml salvaged with the mec (mitoxantrone etoposide cytarabine) regimen

Castagnola, C., Alessandrino, E. P., Pagnucco, G., Bernasconi, P., Lunghi, M., Colombo, A., Brusamolino, E., Bonfichi, M., Corso, A., Lazzarino, M. & Bernasconi, C., 2000, In : Blood. 96, 11 PART II

Research output: Contribution to journalArticle

Mitoxantrone
Cytarabine
Etoposide
Acute Myeloid Leukemia
Refractory materials

Sweet's syndrome and myelodysplasia: Two entities with a common pathogenetic mechanism? A case report

Zappasodi, P., Corso, A. & Del Forno, C., 2000, In : Haematologica. 85, 8, p. 868-869 2 p.

Research output: Contribution to journalArticle

1999

Assessment of renal function in patients with multiple myeloma: The role of urinary proteins

Corso, A., Serricchio, G., Zappasodi, P., Klersy, C., Bosoni, T., Moratti, R., Castagnola, C., Lazzarino, M., Pagnucco, G. & Bernasconi, C., Aug 1999, In : Annals of Hematology. 78, 8, p. 371-375 5 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Creatinine
Kidney
Hexosaminidases
Serum

Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma

Lazzarino, M., Orlandi, E., Montillo, M., Tedeschi, A., Pagnucco, G., Astori, C., Corso, A., Brusamolino, E., Simoncini, L., Morra, E. & Bernasconi, C., 1999, In : Annals of Oncology. 10, 1, p. 59-64 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Cyclophosphamide
Dexamethasone
fludarabine phosphate
Agranulocytosis

Plateau phase in multiple myeloma: An end-point of conventional-dose chemotherapy

Corso, A., Nozza, A., Lazzarino, M., Klersy, C., Zappasodi, P., Arcaini, L. & Bernasconi, C., Apr 1999, In : Haematologica. 84, 4, p. 336-341 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Drug Therapy
Survival
Melphalan
Therapeutics

Transient response of myeloma clone to pamidronate therapy [8]

Corso, A., Astori, C., Orlandi, E., Zappasodi, P., Arcaini, L. & Bemasconi, C., 1999, In : Haematologica. 84, 8, p. 759-760 2 p.

Research output: Contribution to journalArticle

1998

A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome

Bernasconi, P., Cavigliano, P. M., Genini, E., Castagnola, C., Malcovati, L., Calatroni, S., Caresana, M., Boni, M., Alessandrino, E. P., Astori, C., Corso, A. & Bernasconi, C., Sep 1998, In : Cancer Genetics and Cytogenetics. 105, 2, p. 182-186 5 p.

Research output: Contribution to journalArticle

Chromosome Deletion
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Chromosomes, Human, Pair 7
Chromosomes, Human, Pair 5

Management of acute promyelocytic leukemia relapse in the ATRA era

Castagnola, C., Lunghi, M., Corso, A., Tajana, M., Zappasodi, P., Dabusti, M., Lazzarino, M. & Bernasconi, C., Aug 1998, In : Haematologica. 83, 8, p. 714-717 4 p.

Research output: Contribution to journalArticle

Acute Promyelocytic Leukemia
Tretinoin
Recurrence
Idarubicin
Drug Therapy